Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
35 results about "Physical trauma" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Animal control apparatus and methods
InactiveUS20080173257A1Easy to optimizeSighting devicesLiquid transferring devicesEngineeringPhysical trauma
Apparatus and methods for animal control and restraint. In one embodiment, the apparatus comprises a retractable tether (e.g., leash) having a single-handed grip handle which include a built-in chemical repellent. The handle further includes a mechanism for quickly dispensing chemical repellent directionally by initiating a safety and actuating a trigger mechanism. The repellant can be used to rapidly spray one or more animals (such as during a dogfight) so as to minimize physical trauma to the dogs, and emotional trauma to the owner(s). Also, the handle is optionally equipped with a built in light for effective use of the handle (and repellant) in the dark, as well as a retractable mechanism to manage the dispensing and storage of a leash that can be attached to an animal collar.
Owner:STEINER MICHAEL +1
Smart watch with automatic voice recording and alarm
A wearable accoutrement such as a wristwatch records noises within a wearer's vicinity, and white noises may be filtered out to output pure human voices. The voice recording feature can be activated manually or automatically during a “panic mode” as indicated by a loud noise or sudden biological changes such as an increase in heart rate or body temperature. The accoutrement can also monitor other environmental elements such as light, motion and audio and may be paired with a wireless phone such that noise from a stressful event can be sent to a remote server which processes the data. A motion sensor in the accoutrement may also activate an audible alarm in the event of physical trauma to the wearer to induce an attacker to flee.
Owner:SONY CORP
Surrogate
A surrogate for testing an effect of physical trauma on a whole or portion of a natural biological animal body where the surrogate has a surrogate bone or bones and material replicating the effect of flesh around such a bone or bones. Also disclosed are further parts of a natural body which are replicated with surrogate materials in a surrogate construction including skin, tendons, arteries, and joints between bones as well as sensors for measuring the effect of any trauma caused.
Owner:COMMONWEALTH OF AUSTRALIA
Protective suit ventilated by self-powered bellows
InactiveUS20050010996A1Maximum area of bodyIncrease the areaChemical protectionHeat protectionAir cycleParticulates
Protective suits are used to protect the wearer against hazardous materials such as particulates, liquids, chemicals, pathogens, radiation, electromagnetism, physical trauma, heat and for rain protection. They are used to protect the wearer's surrounding in cleanrooms. Medical protective suits are used to prevent the spread of pathogens from the wearer. Unfortunately, they can cause heat stress by reducing air circulation. This invention discloses a protective suit with bellows and dual one-way valves operated by the normal movement of the wearer to draw air through the suit's interior to cool the wearer and provide breathable air. Filters can be placed in the bellows and suit's air vents, or the suit can be made of a filter material to protect the wearer and the surroundings. The disclosed suit is lighter, less expensive and more mobile than prior-art protective ventilated suits that use powered or externally supplied ventilation and cooling devices. It does not depend on limited life portable power sources for ventilation. Filtered air, supplied by the bellows, can be used for breathing, eliminating the need for a separate source of air.
Owner:KK TOSHIBA
Decision support method for casualty treatment using vital sign combinations
InactiveUS20110201905A1Continuous monitoringConfirm and improve uponDiagnostic recording/measuringSensorsTreatment demandWhole blood product
A device and control software and system capable of accepting patient vital sign readings from an oximeter and applying a predetermined decision algorithm that incorporates unique combinations of vital signs and will allow the care giver to continuously monitor and have continuous feedback regarding certain patient vital functions, body trauma status, and immediate treatment needs, such as the patient's likelihood of the onset of shock and the advisability of introducing blood or blood products to the patient.
Owner:OFFICE OF THE GOVERNOR
Ventilated, breathing-powered protection suit
InactiveUS20050015866A1Prevent crashLose air circulationChemical protectionHeat protectionAir cycleEngineering
Protective suits are used to protect the wearer against hazardous materials such as chemicals, pathogens, radioactive particles, electromagnetism, physical trauma and for rain protection. They are used to protect the wearer's surrounding in cleanrooms. Medical protective suits are used to prevent the spread of pathogens from the wearer. Unfortunately, they can cause heat stress by reducing air circulation. This invention discloses a protective suit with a breathing mask and dual one-way valves to draw air through the suit's interior using the forces generated by the wearer's breathing. Filters can be placed in the suit, or the suit can be made of a filter material to protect the wearer and the surroundings. The disclosed suit is lighter, less expensive to produce and more mobile than prior-art protective suit designs that use powered or externally supplied ventilation and cooling devices.
Owner:STEINERT ROBERT BRUCE
Protective suit ventilated by self-powered bellows
InactiveUS20050011517A1Maximum area of bodyPrevent crashChemical protectionHeat protectionParticulatesAir cycle
Protective suits are used to protect the wearer against hazardous materials such as particulates, liquids, chemicals, pathogens, radiation, electromagnetism, physical trauma, heat and for rain protection. They are used to protect the wearer's surrounding in cleanrooms. Medical protective suits are used to prevent the spread of pathogens from the wearer. Unfortunately, they can cause heat stress by reducing air circulation. This invention discloses a protective suit with bellows and dual one-way valves operated by the normal movement of the wearer to draw air through the suit's interior. Filters can be placed in the suit, or the suit can be made of a filter material to protect the wearer and the surroundings. The disclosed suit is lighter, less expensive to produce and more mobile than prior-art protective suit designs that use powered or externally supplied ventilation and cooling devices.
Owner:STEINERT ROBERT BRACE
Sex reversal siRNA of Chinese mitten crab and application of siRNA
InactiveCN109988763AAchieving sexual reversalIncrease success ratePeptidesOther foreign material introduction processesNucleotideInjury mouth
Owner:WEIFANG UNIV OF SCI & TECH
Glycine as a diet supplement for the treatment of a wide range of health problems that result from underlying metabolic disorders
InactiveUS20060052454A1Convenient treatmentOrganic active ingredientsBiocideDietary supplementArthritis
A method of treating or preventing a subject's health problem that is related to an underlying disorder in the functioning of the metabolic system of the subject includes the step of administering a therapeutically effective dosage of glycine. For health problems associated with the subject's bones, cartilage or connective tissue, including degenerative diseases such as arthrosis and arthritis, injuries due to physical trauma, the condition of one's skin, teeth, gums, finger nails, eyes, ears, vocal chords or muscles, or diseases such as osteoporosis, asthma, multiple sclerosis or atherosclerosis, the administering step involves daily ingesting glycine at a rate in the range of 0.1 to 0.7 g / Kg of the subject's body weight.
Owner:HEVIA ENRIQUE MELENDEZ
External chest therapy blanket for infants
InactiveUS20050183722A1Loosen buildupReduce physical traumaRespiratorsPneumatic massagePhysical traumaPhysical therapy
Massaging and compressing the lungs of a patient has been proven effective in loosening mucus buildup. Devices and methods for this purpose have been designed for patients older than infants and toddlers. A method for massaging and compressing the lungs of infants and toddlers has been developed using a device similar to those used for older patients. Such devices use pulsating air to inflate and deflate bladders that are in contact with the patient and apply pressure only to the upper torso of the patient. For older patients, the devices are typically made into a vest and fitted on the patient. For infants and toddlers the device, herein called a J-blanket™, having the same bladder arrangement, is spread flat on a suitable surface and the patient placed on the J-blanket. This reduces the physical trauma to these very young patients. The J-blanket can be fitted with sensors to provide important feedback related to the patient's well-being. The same method can be applied to patients of any age that might experience too great a physical trauma when treated in the conventional fashion.
Owner:BILGI JAGADISH
Catheter with protective barrier member
ActiveUS20100168676A1Surgical instrument detailsIntravenous devicesExtreme temperaturePhysical trauma
A device that shields internal organs and tissues from medical procedures performed within a patient's body, especially in the chest cavity where ablation and related procedures are performed in or near the heart, includes a catheter body, a distal section, and a barrier member that can be inflated with fluid to act as a barrier to extreme temperatures and physical trauma, and be deflated to a smaller size to facilitate entry and removal from the patient's chest cavity. In a more detailed embodiment, the barrier member is a balloon that can protects the esophagus, which can be provided with folds and shape memory elements so that the balloon expands and collapses into predetermined configurations. Fluid is fed to and drawn from the barrier member via an irrigation tubing that extends along a catheter shaft and is in communication with a lumen of a deflectable tubing section that extends through an interior cavity of the barrier member. The catheter can be adapted for uni- or bi-directional deflection.
Owner:BIOSENSE WEBSTER INC
Paste for treating physical trauma
InactiveCN101537030ACompatibility is reasonableWide range of medicinesHeavy metal active ingredientsAnthropod material medical ingredientsSide effectRegimen
The invention discloses a paste for treating physical trauma in the field of Chinese medicaments, which is prepared by using 5 portions of borneol, 150 portions of cochinchina momordica seed, 10 portions of calomel, 500 portions of valelinum Liquidum, 70 portions of fraxinus chinensis, 5 portions of minium and 200 portions of honey as raw materials. The paste has effects of clearing away heat and toxic material, sterilizing and stanching bleeding, relieving swelling and pains, drawing out the pus and promoting tissue regeneration and accelerating wound healing, wherein the effect of relieving pains is particularly outstanding. The paste is also characterized by forming a protective film on the surface of a body to isolate bacteria and viruses and to prevent the bacteria and the viruses from entering the body from wounds so as to prevent and control infection effectively to cure the physical trauma quickly. The paste also has the characteristics of novel and unique formula, reasonable drug mixing, fewer and readily-available components, exact and long-lasting drug effect, short treating period, quick response, remarkable treatment effect, radical prevention of relapse after treatment, no toxic and side effect, and suitability for clinic promotion. The paste has total effective rate of 100 percent and a cure rate of 100 percent for treating the physical trauma, physical traumatic infections, high fever and edema, local tissue necrosis and complications and is the most ideal drug for treating the physical trauma currently.
Owner:葛锐民
Ultrasonic component and peripheral nerve stimulator based apparatus and method for detecting motor nerve feedback
ActiveCN107361794AAccurate quantitative evaluationAvoid damageElectrotherapyOrgan movement/changes detectionPeripheral nerve stimulatorUltrasonic sensor
The invention discloses an ultrasonic component and peripheral nerve stimulator based apparatus and method for detecting motor nerve feedback. The device is characterized in that a peripheral nerve stimulator and an ultrasonic sensor are combined with each other, feedback of muscles on surrounding weak current stimulation or deeper stimulation can be monitored timely, effectively and accurately, and no physical trauma is caused to the body; meanwhile, the device is widely applicable to the field of rehabilitation therapy. With the method, motor nerve properties of a monitoring object can be non-invasively and accurately monitored and evaluated in real time.
Owner:爱纳医疗科技股份有限公司
Spray compositions of chitosan for wound healing
InactiveUS20210401765A1Organic active ingredientsAerosol deliveryUpper urinary tract infectionGYNECOLOGIC DISORDERS
The present invention relates to topical spray compositions comprising chitosan and the process for preparation thereof. The topical spray compositions comprising chitosan are used for the treating burn wounds, wounds resulting from chemical burns, wounds from physical trauma, neuropathic ulcers, pressure sores, diabetic ulcers. Further the spray compositions composition is used for treating gynaecological diseases, urogenital infections (vaginal bacteriosis, urinary tract infection and vaginitis) with good effect, safe, natural, and good biocompatibility by restoring and / or maintaining the pH of vagina. More specifically the present invention relates to topical spray compositions comprising chitosan and carbonic acid and the process for preparation thereof.
Owner:SHILPA MEDICARE LTD
Ointment for treating scars and acne
The invention belongs to the technical field of human face skin drugs and particularly relates to an ointment for treating scars and acne. The ointment is prepared from, by weight, 5-10 parts of cold-pressed linseed oil, 3-5 parts of spreading hedyotis herb extraction liquid, 5-10 parts of C18 fatty alcohol, 3-5 parts of stearic acid, 2-5 parts of glycerin, 5-10 parts of aloe extract liquid and 5-8 parts of deionized water. The ointment is natural, non-irritant, harmless to face skin cells and capable of moisturizing, inhibiting bacteria, treating the acne and repairing physical trauma to a certain degree.
Owner:江海波
Smart watch with automatic voice recording and alarm
Owner:SONY CORP
Treatment of Smell and Taste Disorders Using Orally Administered Interferon-Alpha
InactiveUS20160000879A1Dispersion deliveryPeptide/protein ingredientsInterferon alphaPhysical trauma
The present disclosure is directed to the use of interferon to treat smell and taste disorders. In one embodiment a composition comprising interferon-alpha is administered orally to treat a patient suffering from diminished or distorted senses of smell and taste due to aging, medication usage, viral illness, physical trauma or a chronic medical condition.
Owner:CUMMINS JOSEPH
Catheter with protective barrier member
Owner:BIOSENSE WEBSTER INC
Antibodies to bufadienolides prevent inhibition of Na/K ATPase and prolong survival in shock
The present invention relates to compositions and methods of use thereof for treatment of clinical conditions manifested from and / or exacerbated by a decrease or an inhibition of Na / K ATPase activity. The invention relates to composition comprises monoclonal or polyclonal antibodies to bufalin and / or bufalin sulfate, or vaccination against bufalin and / or bufalin sulfate, which prevents or attenuates inhibition of Na / K ATPase activity thereby attenuating the adverse physiological effects of bufalin and / or bufalin sulfate inhibition. The invention also relates to methods of treating hemorrhagic, septic shock, cardiogenic shock, shock resulting from physical trauma, diabetes, mental depression, bipolar disorder and schizophrenia comprising administering a therapeutically effective amount of an bufalin monoclonal or polyclonal antibody.
Owner:SHOCK THERAPEUTICS BIOTECH INC
System and method of managing personal security
ActiveUS11373513B2Avoid problemsInput/output for user-computer interactionSpecial service for subscribersPhysical traumaDelayed Alarm
Owner:MUSUMANO GREGORY
Biomarkers of Renal Dysfunction
ActiveCN104641236BMaintain abnormal blood pressureAdequate tissue oxygen deliveryDisease diagnosisDiagnostic recording/measuringPhysical traumaHypotension shock
Owner:QUEENS UNIV OF BELFAST +1
Thiazideamide derivative and use thereof
ActiveUS10335417B2High activityImprove abilitiesNervous disorderOrganic chemistrySolventPhysical trauma
Owner:INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
A kind of Lycium barbarum aseptic seedling and method for obtaining callus thereof
InactiveCN103609451BShort cycleOvercoming seasonal selectivity in callusHorticulture methodsPlant tissue cultureEvery Two WeeksPolyethylene glycol
The invention discloses a medlar sterile seedling and a method for obtaining the induced healing of the medlar sterile seedling, belonging to the technical field of plant tissue culture. The method comprises the following steps of drying fruits; disinfecting seeds: carrying out the seed disinfection by using sterile distilled water which contains 70 percent by weight of ethanol and 0.1 percent by weight of TritonX-100 (polyethylene glycol octylphenol ether); germinating seeds: firstly arranging the seeds into a refrigerator at 4 DEG C, standing for 2 days, and then removing the seeds to a culture room at the temperature of 25+ / -2 DEG C with the daily photoperiod of 14 hours to culture for 20+ / -2 days; healing subculture: arranging the seed on a subculture medium, culturing under at 25+ / -2 DEG C in the culture room with the daily photoperiod of 16 hours, and replacing the culture medium every two weeks. According to the method disclosed by the invention, both the medlar sterile seedling and the medlar induced callus are obtained, the step of carrying out physical trauma on the medlar callus in the inducing process of the medlar callus is simplified and the period of obtaining the medlar callus is shortened.
Owner:SHANDONG CROP GERMPLASM CENT
Uniaxially-aligned nanofiber scaffolds and methods for producing and using same
PendingUS20210001010A1Promote wound healingEnlarged cavityOrganic active ingredientsPharmaceutical delivery mechanismWhite blood cellPhysical trauma
Oral cavity wound healing occurs in an environment that sustains ongoing physical trauma and is rich in bacteria. Patients undergoing cleft palate repair have a high degree of wound healing complications, such as oronasal fistula (ONF) formation. Following hard palate injury, ONF was created that demonstrated little change in pro-regenerative monocytes LY6Clo monocytes; however, there were increased M2 macrophages observed. Delivery of FTY720 nanofiber scaffolds following hard palate injury prevented ONF formation, allowed complete wound healing and was associated with increased LY6Clo monocytes and pro-regenerative M2 macrophages. Evaluation of interleukin gene expression revealed reduction in pro-inflammatory IL1 and IL6 and increased expression of pro-regenerative IL10 with FTY720 nanofiber delivery. The ability of FTY720 scaffolds to increase LY6Clo monocytes, increase M2 macrophages and alter the interleukin expression during hard palate mucosal healing demonstrates the ability of a FTY720-based autotherapy to improve oral cavity wound healing.
Owner:ORIDIVUS LLC
Antibodies to bufalin prevent inhibition of Na/K ATPase and prolong survival in shock
Owner:SHOCK THERAPEUTICS BIOTECH INC
Analgesia apparatus for critical patients
The invention discloses an analgesia apparatus for critical patients. Patients in terminal stages of cancer or critical patients have sharp pain locally or generally, and many patients desire to die quickly rather than endure hardships. Family members are reluctant to see that the patients screech painfully, so that the patients take various analgesics or even buy imported analgesics with large sum of money, and some patients even use dolantin and opium as analgesics. Most analgesics cause greater damage to the patients. The analgesia apparatus for critical patients consists of four parts, i.e. a pulse generator, a pulse width setter, a strength adjustor and a power amplifier. The analgesia apparatus blocks nerves and dredges main and collateral channels through peak pulse by means of a principle of acupuncture anesthesia in traditional Chinese medicine, so that the analgesia apparatus can not only relieve pain, but also eliminate blood stasis and focus in the body. Therefore, the patients can sleep and eat, so that the apparatus is remarkable in effect and free from side effects. The produced analgesia apparatus for critical patients can soothe mental and physical trauma of the patients and the family members so as to promote harmonious society.
Owner:任国祚
Adjustable anal surgery platform
The invention relates to a medical device, in particular to an adjustable anal surgery platform. The adjustable anal surgery platform includes an anoscope body and an inner core, the inner core is placed in the anoscope body, and the anoscope body includes an anterior section, an extended section, and an anal section, wherein the anterior section, the extended section, and the anal section are arranged in order from front to back; a control knob is arranged at the tail end of the anal section; the diameter of the extended section is adjustable, compared with the prior art, the anal surgery platform is easy to adjust, the size of an anoscope can be adjusted according to the size of an actual lesion, thus the difficulty of operation is greatly reduced, the success rate of surgery is increased, in addition, an enteric cavity does not need to be inflated with air when the anal surgery platform is in use, the pain of a patient is alleviated, the surgery field of a healer is also stabilized,the success rate of surgery is further increased, the anal surgery platform is suitable for minimally invasive surgery for different patients, an open surgery or laparoscopic surgery is not needed, the physical trauma of the patient is reduced, and the adjustable anal surgery platform is worthy of clinical promotion.
Owner:NANJING PUPAI MEDICAL TECH CO LTD
Carbohydrate Composition and Its Use for the Preparation of a Medicament for Treating or Preventing Pulmonary Inflammation or Acute Respiration Distress Syndrome
InactiveUS20070232568A1Reduced intake of digestible carbohydratesMaintaining or restoring the resistance of mammals to pulmonary inflammationBiocideSugar food ingredientsEnteral administrationMedicine
One aspect of the present invention is concerned with a method of treating or preventing pulmonary inflammation as a complication ensuing from physical trauma, bacteraemia or viral inflection, said method comprising enterally administering at least one or more glutathione promoters selected from: -0.3-20 g, preferably 0.5-5 g pyruvate equivalents; -0.1-5 g, preferably 0.2-2 g oxaloacetate equivalents; -0.01-1 g, preferably 0.02-0.5 g lipoic acid equivalents; and at least 20 g of digestible water soluble carbohydrates, in the form of an aqueous liquid composition containing at least 10 g / l of said digestible water soluble carbohydrates. Another aspect of the invention relates to an aqueous liquid composition suitable for enteral administration containing: 2 to 20 wt. % digestible dissolved carbohydrates; two or more glutathione promoters selected from: 0.5 to 50 g / l pyruvate equivalents; 0.05 to 20 g / l oxaloacetate equivalents; 0.05 to 5 g / l cystein equivalents; and at least 45 wt % water.
Owner:NUTRICIA
An Intelligent Speech Recognition Wrist Sleep Apnea Monitoring System
ActiveCN113397492BLess discomfortAvoid traumaDiagnostic recording/measuringSensorsSound source locationSound sources
Owner:GUANGDONG DELONG INTELLIGENT TECH CO LTD
Spray compositions of chitosan for wound healing
PendingCN112955156AOrganic active ingredientsAerosol deliveryUpper urinary tract infectionGYNECOLOGIC DISORDERS
Owner:SHILPA MEDICARE LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com